I agree that this site is using cookies. You can find further informations here.
X
Georganaki, Maria
24  results:
Search for persons X
?
1

Tailoring vascular phenotype through AAV therapy promotes a..:

Ramachandran, Mohanraj ; Vaccaro, Alessandra ; van de Walle, Tiarne...
Cancer Cell.  41 (2023)  6 - p. 1134-1151.e10 , 2023
Link: https://doi.org/10.1016/..
 
?
2

ELTD1 deletion reduces vascular abnormality and improves T-..:

Huang, Hua ; Georganaki, Maria ; Conze, Lei Liu...
Neuro-Oncology.  24 (2021)  3 - p. 398-411 , 2021
Link: https://doi.org/10.1093/..
 
?
3

Agonistic CD40 therapy induces tertiary lymphoid structures..:

van Hooren, Luuk ; Vaccaro, Alessandra ; Ramachandran, Mohanraj...
Nature Communications.  12 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
4

Tumor endothelial ELTD1 as a predictive marker for treatmen..:

Niinivirta, Marjut ; Georganaki, Maria ; Enblad, Gunilla...
BMC Cancer.  20 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
5

Tumor endothelial cell up-regulation of IDO1 is an immunosu..:

Georganaki, Maria ; Ramachandran, Mohanraj ; Tuit, Sander...
OncoImmunology.  9 (2020)  1 - p. , 2020
Link: https://doi.org/10.1080/..
 
?
6

Vascular Targeting to Increase the Efficiency of Immune Che..:

Georganaki, Maria ; van Hooren, Luuk ; Dimberg, Anna
Frontiers in Immunology.  9 (2018)  - p. , 2018
Link: https://doi.org/10.3389/..
 
?
7

Region-by-region analysis of PET, MRI, and histology in en ..:

Roodakker, Kenney Roy ; Alhuseinalkhudhur, Ali ; Al-Jaff, Mohammed...
European Journal of Nuclear Medicine and Molecular Imaging.  46 (2018)  3 - p. 569-579 , 2018
Link: https://doi.org/10.1007/..
 
?
8

Sunitinib enhances the antitumor responses of agonistic CD4..:

van Hooren, Luuk ; Georganaki, Maria ; Huang, Hua..
Oncotarget.  7 (2016)  31 - p. 50277-50289 , 2016
Link: https://doi.org/10.18632..
 
?
9

VEGF suppresses T‐lymphocyte infiltration in the tumor micr..:

Huang, Hua ; Langenkamp, Elise ; Georganaki, Maria...
The FASEB Journal.  29 (2014)  1 - p. 227-238 , 2014
Link: https://doi.org/10.1096/..
 
?
10

Tailoring vascular phenotype through AAV therapy promotes a..:

Ramachandran, Mohanraj ; Vaccaro, Alessandra ; van de Walle, Tiarne...
Cancer Cell, 1535-6108, 2023, 41:6, s. 1134-1151.  , 2023
Link: http://urn.kb.se/resolve..
 
?
11

ELTD1 deletion reduces vascular abnormality and improves T-..:

Huang, Hua ; Georganaki, Maria ; Conze, Lei Liu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917395/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
12

Agonistic CD40 therapy induces tertiary lymphoid structures..:

van Hooren, Luuk ; Vaccaro, Alessandra ; Ramachandran, Mohanraj...
Nature Communications, 2021, 12:1,.  , 2021
Link: http://urn.kb.se/resolve..
 
?
13

ELTD1-deletion reduces vascular abnormality and improves T-..:

Huang, Hua ; Georganaki, Maria ; Conze, Lei Liu...
Neuro-Oncology, 1522-8517, 2021, 24:3, s. 398-411.  , 2021
Link: http://urn.kb.se/resolve..
 
?
14

Tumor endothelial ELTD1 as a predictive marker for treatmen..:

Niinivirta, Marjut ; Georganaki, Maria ; Enblad, Gunilla...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179003/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
15

Tumor endothelial ELTD1 as a predictive marker for treatmen..:

Niinivirta, Marjut ; Georganaki, Maria ; Enblad, Gunilla...
BMC Cancer, 1471-2407, 2020, 20,.  , 2020
Link: http://urn.kb.se/resolve..
 
1-15